Delivery Order SPE2DB22D1017-SPE2DB25FG8JS
Award Date 7/29/25
Potential Completion Date 7/30/25
Potential Value $7.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $15,115.77 to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 mg tablets (90-count supply). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 30, 2025, and represents a continuation of pharmaceutical supply fulfillment under the company's existing contract vehicle with DLA. MYRBETRIQ (mirabegron) is a beta-3 agonist used in the treatment of overactive bladder, indicating this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 mg tablets (90 count) on September 10, 2025, with a ceiling value of $7,323.42 and firm fixed pricing. This non-set-aside, competitively awarded contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MYRBETRIQ ER 25 mg tablets (90-count) valued at $5,569.27 under a firm fixed price contract. This award, issued on July 31, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MYRBETRIQ (mirabegron) is a beta-3 agonist medication used to treat...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 mg tablets (90-count supply) on September 9, 2025, with a ceiling value of $3,650.59. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and represents a non-competitive set-aside contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for MYRBETRIQ ER 50 MG tablets (quantity: 90-count supply) with a ceiling value of $3,120.05 under a firm fixed price contract. This is a non-set-aside award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion potential value through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) valued at $13,844.76. This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The order is scheduled for completion by September 19, 2025, and will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $20,957.72 to AmerisourceBergen Drug Corp for the supply of MYRBETRIQ ER 50 mg tablets (90-count units). This competitive award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- This delivery order, valued at $1,219.26, was awarded on August 29, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MYRBETRIQ ER 25 mg tablets (90-count). The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. Performance will be completed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $7,133.83 to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 MG tablets (90-count supply) on June 25, 2025, with completion targeted for June 26, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $7,055.56 for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a medication used for the treatment of overactive bladder. The contract has an ultimate completion date of January 10, 2024 and is structured as a Firm Fixed Price arrangement. Amerisourcebergen holds a...